Seychelles

Reimbursed Care Access

Seychelles maintains a strict controlled-substance regime under the Misuse of Drugs Act, 2016, with most classic psychedelics criminalised and severe penalties for trafficking and possession. Medical access is limited: generic ketamine is used as an essential anaesthetic in health services, but novel psychedelic medicines (psilocybin, MDMA, esketamine, DMT variants, ibogaine, mescaline and 2C‑series) have no authorised, reimbursed therapeutic pathway in the country outside of standard medical/anaesthetic use or regulated clinical research.